#50 - Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation episode artwork

EPISODE · Aug 19, 2025 · 20 MIN

#50 - Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation

from BioBreakthroughs · host Slice of Healthcare LLC

Join us on the latest episode! Our Guest: Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation.What you'll get out of this episode:PDS Biotechnology targets the key limitations of CAR T and cancer vaccine therapies using lipid nanoparticle-based immunotherapy.Their lead candidate, PDS0101, demonstrated over 2x improvement in survival for HPV-positive head and neck cancer.The platform technology shows consistent efficacy across multiple independent Phase 2 trials.Late-stage clinical programs focus on HPV16+ head and neck cancer, with additional trials for colorectal, prostate, and MUC1+ cancers.To Learn More About Our Guest And Their Company:Guest LinkedIn https://www.linkedin.com/in/frank-bedu-addo-4797947/Company LinkedIn https://www.linkedin.com/company/pds-biotechnology-corporation/ Website https://www.pdsbiotech.com/ Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Join us on the latest episode! Our Guest: Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation.What you'll get out of this episode:PDS Biotechnology targets the key limitations of CAR T and cancer vaccine therapies using lipid nanoparticle-based immunotherapy.Their lead candidate, PDS0101, demonstrated over 2x improvement in survival for HPV-positive head and neck cancer.The platform technology shows consistent efficacy across multiple independent Phase 2 trials.Late-stage clinical programs focus on HPV16+ head and neck cancer, with additional trials for colorectal, prostate, and MUC1+ cancers.To Learn More About Our Guest And Their Company:Guest LinkedIn https://www.linkedin.com/in/frank-bedu-addo-4797947/Company LinkedIn https://www.linkedin.com/company/pds-biotechnology-corporation/ Website https://www.pdsbiotech.com/ Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

NOW PLAYING

#50 - Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation

0:00 20:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBreakthroughs?

This episode is 20 minutes long.

When was this BioBreakthroughs episode published?

This episode was published on August 19, 2025.

What is this episode about?

Join us on the latest episode! Our Guest: Frank Bedu-Addo, President and CEO at PDS Biotechnology Corporation.What you'll get out of this episode:PDS Biotechnology targets the key limitations of CAR T and cancer vaccine therapies using lipid...

Can I download this BioBreakthroughs episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!